Sign Up Today and Learn More About Sanegene Bio Stock
Invest in or calculate the value of your shares in Sanegene Bio or other pre-IPO companies through EquityZen's platform.
Sanegene Bio Stock
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
About Sanegene Bio Stock
Founded
2021
Headquarters
Woburn, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Sanegene Bio Press Mentions
Stay in the know about the latest news on Sanegene Bio
Genentech licenses Sanegene’s RNAi asset in $1.7B deal
bioworld • Feb 04, 2026
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech
prnewswire • Feb 02, 2026
Sanegene Bio Secures Over $110 Million in Series B Financing for RNAi Programs and Disease Development
venturecapital • Dec 20, 2025
Sanegene Bio Closes Over $110 Million Series B
vcnewsdaily • Dec 20, 2025
The Week’s 10 Biggest Funding Rounds: Security And Energy Deals Top The List
news • Dec 12, 2025
Sanegene Bio Management
Leadership team at Sanegene Bio
Founder & CEO
Weimin Wang
Founder & Chief Scientific Officer
Shiyu Wang
Join now and verify your accreditation status to gain access to:
- Sanegene Bio Current Valuation
- Sanegene Bio Stock Price
- Sanegene Bio Management
- Available deals in Sanegene Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Sanegene Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Sanegene Bio Revenue and Financials
- Sanegene Bio Highlights
- Sanegene Bio Business Model
- Sanegene Bio Risk Factors
- Sanegene Bio Research Report from SACRA Research
Trading Sanegene Bio Stock
How to invest in Sanegene Bio stock?
Accredited investors can buy pre-IPO stock in companies like Sanegene Bio through EquityZen funds. These investments are made available by existing Sanegene Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Sanegene Bio stock?
Shareholders can sell their Sanegene Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."